Implications for colistin use in patients with cystic fibrosis (CF). Letter in response to " Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig herds" by Callens et al. [Prev. Vet. Med. 106 (2012) 53-62].

Preventive Veterinary Medicine

Volumn 107, Issue 3-4, 2012, Pages 286-287

  Moore, John E ^a   Elborn, J Stuart ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; FEMALE; LETTER; MALE; SWINE DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, BACTERIAL; FEMALE; MALE; SWINE DISEASES;

SUIDAE;

EID: 84868200136     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2012.09.006     Document Type: Letter

References (8)

1. Anon Annual Report 2010 2010, Cystic Fibrosis Registry of Ireland. http://www.cfri.ie/docs/annual_reports/CFRI2010.pdf.
2. Callens B., Persoons D., Maes D., Laanen M., Postma M., Boyen F., Haesebrouck F., Butaye P., Catry B., Dewulf J. Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig herds. Prev. Vet. Med. 2012, 106:53-62.
3. de Jong A., Thomas V., Simjee S., Godinho K., Schiessl B., Klein U., Butty P., Vallé M., Marion H., Shryock T.R. Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals. J. Antimicrob. Chemother. 2012, 67:638-651.
4. Devaney J., Glennon M., Farrell G., Ruttledge M., Smith T., Houghton J.A., Maher M. Cystic fibrosis mutation frequencies in an Irish population. Clin. Genet. 2003, 63:121-125.
5. Lyczak J.B., Cannon C.L., Pier G.B. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 2002, 15:194-222.
6. Rajan S., Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 2002, 17:47-56.
7. Rao P., McCaughan J., McCalmont M., Goldsmith C.E., Hall V., Millar B.C., McCann M.A., Downey D.G., Rendall J.C., Elborn J.S., Moore J.E. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients. J. Cyst. Fibros. 2012, 11:349-352.
8. WHO WHO Critically Important Antimicrobials for Human Medicine: Categorization for the Development of Risk Management Strategies to Contain Antimicrobial Resistance due to Non-Human Antimicrobial Use. Report of the Second WHO Expert Meeting Copenhagen, 29-31 May 2007 2007, http://www.who.int/foodborne_disease/resistance/antimicrobials_human.pdf.